News | November 14, 2021
Alarming rise in diabetes amongst children and adolescents in India
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
Second interchangeable biosimilar product approved by agency
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
The FDA also approved Repatha as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia (HoFH) for younger pediatric patients
In participants 5 to 11 years of age, the vaccine was safe, well-tolerated and showed robust neutralising antibody responses. Results in children under 5 years of age are expected as soon as later this year
Subscribe To Our Newsletter & Stay Updated
